Silo Pharma Closes $3.5M Private Placement, Adds Resale Registration Rights
SILO sits 71% above its 52-week low of $3.315 on elevated volume (1.9× avg).
Summary
Silo Pharma closed a private placement with institutional investors, raising approximately $3.5 million in net proceeds through common stock and warrants. This follows the July 10 announcement of a placement expected to raise up to $11.7 million; the final net amount is lower, reflecting the initial tranche. The company also granted resale registration rights, requiring an SEC filing within 15 days and effectiveness within 30-60 days, which could pressure the stock as shares become tradable. With a market cap around $6.4 million, the raise is highly dilutive and underscores the company's urgent need for capital. The proxy seeking to increase authorized shares to 250 million signals further dilution ahead.
At the time of this announcement, SILO was trading at $5.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.4M. The 52-week trading range was $3.32 to $15.15. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.